Clinical Trials Directory

Trials / Completed

CompletedNCT02512731

Intraoperative Fluid Therapy for Deceased Donor Renal Transplantation

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
University Health Network, Toronto · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Delayed graft function (DGF) is defined as requirement for dialysis in the first week following kidney transplantation. DGF is a common complication occurring in 39% of the deceased donor renal transplants at the investigators' institution with significant cost and outcome implications. The 3 major risk factors for DGF are donor graft characteristics, recipient factors and perioperative management. The most easily modifiable of these factors is perioperative management, in particular intraoperative fluid therapy. The investigators propose to compare the amount of fluid administered using the current standard of care with the fluid administered when optimizing the cardiac output (CO) using Esophageal Doppler Monitoring (EDM) to guide fluid therapy. EDM measures blood flow in the descending aorta, optimizing stroke volume (SV) and cardiac output (CO) by indicating when fluid administration fails to produce an increase in CO.

Conditions

Interventions

TypeNameDescription
DEVICEEsophageal Doppler MonitorEsophageal doppler monitoring (EDM) is a minimally invasive means of continuously measuring the cardiac output from the pattern of blood flow in the descending thoracic aorta.

Timeline

Start date
2012-06-01
Primary completion
2015-09-01
Completion
2016-12-01
First posted
2015-07-31
Last updated
2016-12-05

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT02512731. Inclusion in this directory is not an endorsement.